RSV Vaccines for Senior Adults Linked to Guillain-Barré Syndrome
On Feb. 29, 2024, the U.S. Centers for Disease Control and Prevention’s (CDC) Advisory Committee on Immunization Practices (ACIP) presented a preliminary analysis that showed that 23 adults over the age of 65 who received a respiratory syncytial virus (RSV) vaccine developed Guillain-Barré syndrome (GBS).1 When a person develops GBS, including after an infection or […]
Influenza Vaccines Only 42 Percent Effective in Adults This Year
The influenza vaccines currently being administered in the United States are estimated by the U.S. Centers for Disease Control and Prevention (CDC) to be 42 percent effective in adults. This is an interim estimate for the 2023-2024 “flu season” published in the agency’s Morbidity and Mortality Weekly Report (MMWR) on Feb. 29, 2024.1 2 3 […]
Testimony of Barbara Loe Fisher at Sen. Ron Johnson Roundtable on Federal Health Agencies and COVID Cartel
Barbara Loe Fisher, Co-founder & President of the National Vaccine Information Center, sheds light on the history of the 42-year old vaccine safety and informed consent movement in the U.S., censorship and government accountability in her testimony part of a Feb. 26, 2024 roundtable discussion sponsored by U.S. Senator Ron Johnson, titled “Federal Health Agencies […]
CDC Refused to Issue Alert About COVID Vaccine and Heart Inflammation for Fear of Causing Public Panic
An e-mail recently obtained by The Epoch Times reveals that the U.S. Centers for Disease Control and Prevention (CDC) drafted, but never sent, an alert to the U.S. public about the link between COVID-19 vaccines and myocarditis (inflammation of the heart muscle) because CDC officials worried that people would panic. The e-mail, dated May 15, […]
CDC Reports Errors in RSV Vaccines Given to Pregnant Woman, Monoclonal Antibody Shots to Children
A new problem involving the RSV (Respiratory Syncytial Virus) vaccines given to adults over age 60 and monoclonal antibody shots given to infants and children has been highlighted in a recent emergency newsletter called the U.S. Centers for Disease Control and Prevention (CDC) Clinician Outreach and Communication Activity, which is distributed to health care providers.1 […]
BARDA Awards $9.27 Million Contract to Evaluate Oral Pill COVID Vaccine
Biotechnology firm Vaxart, Inc. announced on Jan. 19, 2024 that it received a $9.27 million contract from the U.S. Biomedical Advanced Research and Development Authority (BARDA) to fund preparations for a Phase IIb clinical trial to evaluate the company’s oral pill XXB COVID-19 vaccine candidate. The trial is expected to involve 10,000 participants and will […]